Coronary computed tomography angiography (CCTA) is a reliable screening method of patients with coronary artery disease (CAD). CCTA is capable to assess both coronary stenosis and plaque morphology, but does not provide hemodynamic characterization of the coronary lesions. However, the severity of coronary stenosis does not always reflect the hemodynamic significance of the plaque. Invasive fractional flow reserve (FFR) is considered the gold standard for the functional evaluation of a potential ischemia-causing stenosis. FFR derived from CCTA (FFR-CT) is a new noninvasive diagnostic tool, using a typically acquired CCTA, without the need for any further radiation or medication. Additional functional assessment of the coronary lesions permits a more complex characterization of CAD patients. Based on the FFR-CT examination, patients who need invasive coronary intervention can be selected more precisely, and a more personalized and optimized treatment can be provided.
INTroDUCTIoN
Cardiovascular diseases are the number one cause of death and long-term disability in industrialized countries, mainly due to coronary artery disease (CAD). Despite the new, improved screening methods (coronary computed tomography angiography -CCTA, inflammatory biomarkers) and therapeutic modalities, morbidity and mortality caused by CAD have shown increasing rates in the last decades, and several prospective studies suggest that this tendency will continue globally. 1 In addition, only in the USA, CAD morbidity is predicted to increase with 8.6% by 2030. 2 In the majority of the affected population, acute myocardial infarction (AMI) and sudden cardiac death represent the first manifestation of CAD, which means that half of the population at risk does not experience any symptoms before the major coronary event occurs. 3 Effective prevention and treatment of CAD could reduce the prevalence of acute coronary events and ameliorate morbidity and mortality rates. 4 Noninvasive assessment of the coronary arteries could play an important role in patient risk stratification; however, selecting patients at risk for acute coronary events remains an important challenge in cardiovascular imaging. Currently, coronary angiography is considered the gold standard for the assessment of the integrity of the coronary arteries. It is able to identify luminal narrowing lesions above 20-30%, but does not provide information about the features of plaque morphology. Current strategies do not focus sufficiently on the characterization of coronary atherosclerotic plaques, but mostly on the detection of myocardial ischemia and hemodynamically significant stenosis, though in many cases, due to positive remodeling, the plaques that are prone to rupture do not cause significant luminal narrowing on the coronary angiography. 5 The recent guidelines of the European Society of Cardiology (ESC) strongly recommend the use of CCTA as a first-line noninvasive functional assessment of myocardial ischemia in patients with angina-like symptoms that might me caused by obstructive CAD. 3 
roLE of CCTA As A NoNINvAsIvE EvALUATIoN of CArDIovAsCULAr rIsk
CCTA is a widely used diagnostic method, which has demonstrated its reliability in the screening of patients with suspected obstructive CAD. The advantage of this imaging technique is that it is capable of to assess both the severity of coronary stenosis and plaque morphology. 6 Based on CCTA examinations, it was demonstrated that plaques that are prone to rupture have a different morphological structure than stable plaques. According to these findings, CCTA helps to define the lesions that need invasive coronary intervention, preventing adverse coronary events. 7 Recently published studies have shown that the characterization of morphological structure and of the atherosclerotic plaque burden using CCTA was superior in the prediction of major coronary events compared to conventional coronary angiography. 8 Based on CCTA imaging, by comparing morphological features, coronary plaques can be defined as stable or vulnerable ones. Vulnerable plaques are larger in size than stable lesions and exhibit a large lipid-rich necrotic core with a low CT attenuation (<30 Hounsfield Units). Spotty calcification is another characteristic feature of vulnerability, defined as small, dense plaque parts surrounded by non-calcified plaque tissue. Positive remodeling often occurs in vulnerable plaques, consisting of compensatory enlargement of the affected vessel, the size increase of the lesion resulting in preservation of the vascular lumen, without significant stenosis on coronary angiogram. 9 The napkin-ring sign is a relatively recent discovery, a qualitative plaque feature, described as a central low CT attenuation area supposedly in contact with the vascular lumen, surrounded with higher CT attenuation plaque tissue. 10 Althogu CCTA is able to provide a complex characterization and risk stratification based on the morphological characteristics of the coronary lesions compared to invasive coronary angiography (ICA), functional assessment of these plaques is necessary in order to determine the hemodynamic significance and their role in causing ischemia.
CCTA-bAsED fUNCTIoNAL PLAqUE ChArACTErIzATIoN
General atherogenic risk factors (smoking, arterial hypertension, diabetes mellitus etc.) are affecting all segments of the coronary system, even though the luminal narrowing coronary lesions appear only in some sections of the coronary arteries such as the outer walls of bifurcations, the inner curve of the arteries, or in side branches. Hemodyna-mic factors (endothelial shear stress -ESS) are considered to play an important role in the development and localization of coronary atherosclerotic plaques. 11 Persistently low EES induces cell apoptosis and inflammation with local oxidative stress and increased LDL uptake, initiating thereby an atherogenic process. Furthermore, the majority of vulnerable plaques are localized in low ESS segments. At the same time, high ESS facilitates plaque destabilization by regression of fibrous tissue and expansion of the necrotic core. 12 Detection of hemodynamically significant coronary stenoses is essential in the treatment of patients with CAD. A number of large clinical trials have demonstrated that revascularization of a non-significant coronary artery stenosis affects the functional status and clinical outcome of the patient and it is not superior to optimal medical therapy. [13] [14] [15] Invasive fractional flow reserve (FFR) is considered the gold standard for the functional evaluation of a potential ischemia-causing stenosis, also improving diagnostic accuracy and effects on therapy and clinical outcome. 13 FFR represents the rate between the pressure determined distally to the coronary stenosis and the aortic pressure, measured after the administration of a hyperemic agent (e.g., 100-200 mcg of adenosine depending on the selected vessel, papaverine, nitroprusside, nicorandil) causing maximal hyperemia of the coronary vessels. FFR was established as a diagnostic tool to assess the functional impact of an intermediate, stabile coronary plaque. As determined by invasive FFR measurement, only half of the intermediate stenoses (a stenosis of 50-75%, determined by ICA) lead to significant hemodynamic changes. 15 A large number of patients present multiple atherosclerotic coronary lesions, and FFR measurement is able to detect the ischemia causing the culprit lesion. It was reported that intermediate lesions with modified FFR and abnormal ESS tend to transform into rupture-prone lesions. FFR-guided PCI is associated with lower rates of events and incidence of urgent revascularization. Studies have shown that only less than 1% of patients with intermediate lesions with normal FFR (>0.8) presented with myocardial infarction within 5 years. Based on the results published by Muller et al., non-ischemia-causing lesions, determined by invasive FFR measurements, should be treated with conservative medical treatment instead of invasive coronary approach, as this group of patients have exhibited better outcomes in terms of long-term mortality. 16 Computational fluid dynamics technology permits the calculation of coronary blood flow and pressure, as well as noninvasive FFR calculation, without the need for additional investigations, image acquisition, and medications, or even modification of the CCTA protocol. FFR-CT can be calculated from a typically acquired CCTA examination. CCTA itself can accurately assess and identify vulnerable coronary plaques prone to rupture, but cannot accurately identify a functionally significant stenosis. Adding computational fluid dynamics to conventional CCTA images enables the localization of the ischemia-causing lesions prior to an invasive cardiac intervention. Recalculation of coronary blood flow and FFR from CCTA scans can be used to predict the hemodynamic effects of stent implantation in a lesion-specific manner, predicting the therapeutic benefits of coronary revascularization. 17 In the Diagnosis of Ischemia-Causing Stenoses Obtained Via Noninvasive Fractional Flow Reserve (DISCOVER-FLOW) trial, FFR-CT was compared with invasive FFR, having a per-vessel accuracy of 84.3%, sensitivity of 87.9%, and specificity of 82.2%. 18 In addition, the Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography (De-FACTO) trial, a multicenter international study on 252 patients that evaluated the diagnostic performance of FFR-CT, has shown that FFR-CT was more effective in identifying ischemic lesions than CCTA, having a higher accuracy (73% vs. 64%), sensitivity (90% vs. 84%), and specificity (54% vs. 42%). 19 DIsCUssIoN CCTA has the ability to assess noninvasively the coronary vessels and to identify and localize the lumen-narrowing lesions. It can also be used to obtain an accurate characterization and risk stratification of the coronary lesions. As a result of technological development, with substantial decrease in radiation doses, CCTA provides an optimal noninvasive tool for the reliable screening of obstructive CAD. In addition, CCTA can provide important morphological data, therefore it is capable of the morphological characterization of the atherosclerotic lesions, it can indicate the calcification level of the coronary system, plaque composition, lipid content. It can also identify the vulnerable markers of coronary plaque such as the napkin-ring sign, spotty calcification, positive vessel remodeling, as well as low CT attenuation zones with large necrotic core. 10 CCTA can also be used for the functional assessment of coronary plaques, using FFR-CT and ESS to identify the ischemia-causing stenosis. With "virtual stenting" of the coronary lesions, it can predict the hemodynamic effects of coronary revascularization. 17 Modified FFR-CT or ESS provides additional information on risk stratification of the lesion. Functional characteristics added to CCTA images lead to a better characterization of the coronary lesion and permit new opportunities for the noninvasive detection of vulnerable plaques.
CoNCLUsIoN
FFR-CT and ESS can play an important role in the selection of therapeutic choice and in the assessment of plaque evolution, as well as in the mapping of hemodynamic changes following the percutaneous coronary intervention. Novel imaging techniques allow both morphological and functional noninvasive assessment of coronary artery plaques, which provide essential information for proper follow-up and treatment for patients with CAD.
